Topoisomerase I interactive agents

P Kellie Turner1, Lisa C Iacono, Clinton F Stewart

  • 1Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN 38105, USA.

Cancer Chemotherapy and Biological Response Modifiers
|September 2, 2004
PubMed

Insights

Understanding topoisomerase I agents is key to improving cancer therapy. Research focuses on mechanisms, overcoming resistance, and optimizing dosing for better antitumor activity and reduced toxicity.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Topoisomerase I interactive agents are crucial in cancer therapy.
  • Maximizing their therapeutic index requires deeper mechanistic insight.

Purpose of the Study:

  • Elucidate mechanisms of cell death induced by topoisomerase I agents.
  • Investigate and circumvent ABC transporter-mediated resistance.
  • Optimize dosing strategies for enhanced antitumor activity and reduced toxicity.

Main Methods:

  • Preclinical studies to understand drug-induced cell death.
  • Research into the role of ABC transporters in drug resistance.
  • Translational research linking preclinical findings to clinical trial design.

Main Results:

  • Protracted dosing of topoisomerase I agents shows enhanced antitumor activity.
  • Clinical trials are beginning to support preclinical dosing observations.
  • Understanding dose-limiting toxicities is crucial for optimal agent use.

Conclusions:

  • Further research into topoisomerase I agent mechanisms is essential.
  • Overcoming drug resistance and optimizing dosing will improve therapeutic outcomes.
  • Ongoing development of new topoisomerase I agents offers future therapeutic potential.

Related Concept Videos

DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types.  Type I...
DNA Helicases00:55

DNA Helicases

DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Translesion DNA Polymerases02:10

Translesion DNA Polymerases

Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...